Former phase 1 oncologist and neuroendocrine tumor specialist turned biotech leader Nanu Das joins host Taymeyah Al-Toubah to talk pivots, patient impact, and why early-stage trials are becoming the “new phase two.”

Why hit play:

• Hear the moment Nanu knew he had to leave clinic life, despite loving patient care.
• Steal his framework for choosing mentors (and being the kind of mentee they fight to help).
• Learn why your first job in pharma shapes your influence on study design.
• See how targeted imaging could replace repeat biopsies in cancer care.
• Decide if AI in oncology is hype or a quiet revolution in the making.

Send this to the friend debating a big career pivot, then tag @taytalks_pod with your takeaway so we can repost it.

✅ Subscribe on Apple Podcasts, Spotify, or your favorite app—so you never miss a TayTalks deep-dive on nonlinear paths and full-circle moments.

🎙️ Come for the science. Stay for the reminder that you can change the system without losing yourself in it.

🤍 If this episode resonated:

• Share it with one friend who needs to hear it.
• Tag @taytalks_pod with your takeaway so we can repost you.
• Leave a quick rating on Apple or Spotify. Your words help more ambitious humans find the show.